MRT67307 99%

MRT67307

源叶(MedMol)
S81227
1190378-57-4
C26H36N6O2
464.603
cyclobutanecarboxylic acid {3-[5-cyclopropyl-2-(3-morpholin-4-ylmethyl-phenylamino)-pyrimidin-4-ylamino]-propyl}-amide; 1FV; N-{3-[(5-Cyclopropyl-2-{[3-(Morpholin-4-Ylmethyl)phenyl]amino}pyrimidin-4-Y
品牌 货号 产品规格 价格(RMB) 库存(上海) 北京 武汉 南京 购买数量
源叶(MedMol) S81227-5mg 99% ¥220.00元 5 - - -
源叶(MedMol) S81227-10mg 99% ¥370.00元 10 - - -
源叶(MedMol) S81227-25mg 99% ¥610.00元 7 - - -
源叶(MedMol) S81227-50mg 99% ¥970.00元 3 - - -
源叶(MedMol) S81227-100mg 99% ¥1740.00元 预计交期:2-3天 - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品

产品介绍

MRT67307 is a dual inhibitor of the IKKε and TBK-1 with IC50s of 160 and 19 nM, respectively. MRT67307 also inhibits ULK1 and ULK2 with IC50s of 45 and 38 nM, respectively. MRT67307 also blocks autophagy in cells
产品描述: MRT67307 is a dual inhibitor of the IKKε and TBK-1 with IC50s of 160 and 19 nM, respectively. MRT67307 also inhibits ULK1 and ULK2 with IC50s of 45 and 38 nM, respectively. MRT67307 also blocks autophagy in cells
靶点: TBK1:19 nM (IC50, at 0.1 mM ATP);IKKε:160 nM (IC50, at 0.1 mM ATP);ULK2:38 nM (IC50);ULK1:45 nM (IC50);Autophagy;IκB/IKK; Autophagy
参考文献: 1. Clark K, et al. Novel cross-talk within the IKK family controls innate immunity. Biochem J. 2011 Feb 15;434(1):93-104. 2. Petherick KJ, et al. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015 May 1;290(18):11376-83. 3. Zhu Z, et al. Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. 26.37Cancer Discov. 2014 Apr;4(4):452-65.
溶解性: DMSO  :  ≥  100  mg/mL  (215.24  mM)
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.152 ml 10.762 ml 21.524 ml
5 mM 0.43 ml 2.152 ml 4.305 ml
10 mM 0.215 ml 1.076 ml 2.152 ml
50 mM 0.043 ml 0.215 ml 0.43 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×

相关产品